A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients von de Jonge, A. Vera, van Werkhoven, Erik, Dinmohamed, Avinash G., Nijland, Marcel, Zwinderman, Aeilko H., Bossuyt, Patrick M., Veldhuis, Martine S., Rutten, Emma G. G. M., Mous, Rogier, Vermaat, Joost S. P., Sandberg, Yorick, de Jongh, Eva, Bilgin, Yavuz M., Boersma, Rinske, Koene, Harry, Kersten, Marie José, de Jong, Daphne, Chamuleau, Martine E. D.

Volltext

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment von van der Horst, Hilma J., de Jonge, A. Vera, Hiemstra, Ida H., Gelderloos, Anne T., Berry, Daniella R. A. I., Hijmering, Nathalie J., van Essen, Hendrik F., de Jong, Daphne, Chamuleau, Martine E. D., Zweegman, Sonja, Breij, Esther C. W., Roemer, Margaretha G. M., Mutis, Tuna

Volltext

Taking care: Anticipation, extraction and the politics of temporality in autism science von Lappé, Martine D

Volltext

Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies von de Jonge, Anna Vera, Csikós, Tamás, Eken, Merve, Bulthuis, Elianne P, Poddighe, Pino J, Roemer, Margaretha G M, Chamuleau, Martine E D, Mutis, Tuna

Volltext

Survival disparities between children and adolescents and young adults for the major subtypes of non-Hodgkin lymphoma in the Netherlands: a large population-based study von Schulpen, Maya, Beishuizen, Auke, Chamuleau, Martine E D, Dinmohamed, Avinash G, Meyer-Wentrup, Friederike A G, Vormoor, H Josef, Van der Wagen, Lotte E, Minnema, Monique C, Loeffen, Jan L C, Karim-Kos, Henrike E

Volltext

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering von Oostindie, Simone C, van der Horst, Hilma J, Lindorfer, Margaret A, Cook, Erika M, Tupitza, Jillian C, Zent, Clive S, Burack, Richard, VanDerMeid, Karl R, Strumane, Kristin, Chamuleau, Martine E D, Mutis, Tuna, de Jong, Rob N, Schuurman, Janine, Breij, Esther C W, Beurskens, Frank J, Parren, Paul W H I, Taylor, Ronald P

Volltext

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics von Bult, Johanna A. A., Huisman, Francien, Zhong, Yujie, Veltmaat, Nick, Kluiver, Joost, Tonino, Sanne H., Vermaat, Joost S. P., Chamuleau, Martine E. D., Diepstra, Arjan, van den Berg, Anke, Plattel, Wouter J., Brink, Mirian, Nijland, Marcel

Volltext

Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands von Pennings, Elise R. A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F. M., Issa, Djamila E., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.

Volltext

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA von Veltmaat, Nick, Zhong, Yujie, de Jesus, Filipe Montes, Tan, Geok Wee, Bult, Johanna A. A., Terpstra, Martijn M., Mutsaers, Pim G. N. J., Stevens, Wendy B. C., Mous, Rogier, Vermaat, Joost S. P., Chamuleau, Martine E. D., Noordzij, Walter, Verschuuren, Erik A. M., Kok, Klaas, Kluiver, Joost L., Diepstra, Arjan, Plattel, Wouter J., van den Berg, Anke, Nijland, Marcel

Volltext

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma von Maas, Carolien C. H. M., van Klaveren, David, Durmaz, Müjde, Visser, Otto, Issa, Djamila E., Posthuma, Eduardus F. M., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.

Volltext

Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018 von Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F. M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M. A., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.

Volltext

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma von Zinzani, Pier Luigi, Karlin, Lionel, Radford, John, Caballero, Dolores, Fields, Paul, Chamuleau, Martine E D, d'Amore, Francesco, Haioun, Corinne, Thieblemont, Catherine, González-Barca, Eva, García, Carlos Grande, Johnson, Peter W, van Imhoff, Gustaaf W, Ng, Thomas, Dwyer, Karen, Morschhauser, Franck

Volltext

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study von Hutchings, Martin, Mous, Rogier, Clausen, Michael Roost, Johnson, Peter, Linton, Kim M, Chamuleau, Martine E D, Lewis, David John, Sureda Balari, Anna, Cunningham, David, Oliveri, Roberto S, Elliott, Brian, DeMarco, Dena, Azaryan, Ada, Chiu, Christopher, Li, Tommy, Chen, Kuo-mei, Ahmadi, Tahamtan, Lugtenburg, Pieternella J

Volltext

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment von Westers, Theresia M., Alhan, Canan, Chamuleau, Martine E.D., van der Vorst, Maurice J.D.L., Eeltink, Corien, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A.

Volltext

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma von Al-Sarayfi, Diana, Meeuwes, Frederik O., Durmaz, Müjde, Issa, Djamila E., Brouwer, Rolf E., Beeker, Aart, van Rhenen, Anna, Mutsaers, Pim G. N. J., Böhmer, Lara H., van der Poel, Marjolein W. M., te Boome, Liane, van Meerten, Tom, Chamuleau, Martine E. D., Zijlstra, Josée M., Brink, Mirian, Nijland, Marcel

Volltext

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice von Mendeville, Matias, Roemer, Margaretha G. M., Los-de Vries, G. Tjitske, Chamuleau, Martine E. D., de Jong, Daphne, Ylstra, Bauke

Volltext

DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies von Oostindie, Simone C., van der Horst, Hilma J., Kil, Laurens P., Strumane, Kristin, Overdijk, Marije B., van den Brink, Edward N., van den Brakel, Jeroen H. N., Rademaker, Hendrik J., van Kessel, Berris, van den Noort, Juliette, Chamuleau, Martine E. D., Mutis, Tuna, Lindorfer, Margaret A., Taylor, Ronald P., Schuurman, Janine, Parren, Paul W. H. I., Beurskens, Frank J., Breij, Esther C. W.

Volltext

Non‐inflammatory nodule formation after hyperdiluted calcium hydroxyapatite treatment in the neck area von Nipshagen, Martine D., Velthuis, Peter J., Cook, Elizabeth, Mosmuller, David G. M.

Volltext

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial von Zelenetz, Andrew D., Salles, Gilles, Mason, Kylie D., Casulo, Carla, Le Gouill, Steven, Sehn, Laurie H., Tilly, Herve, Cartron, Guillaume, Chamuleau, Martine E.D., Goy, Andre, Tam, Constantine S., Lugtenburg, Pieternella J., Petrich, Adam M., Sinha, Arijit, Samineni, Divya, Herter, Sylvia, Ingalla, Ellen, Szafer-Glusman, Edith, Klein, Christian, Sampath, Deepak, Kornacker, Martin, Mobasher, Mehrdad, Morschhauser, Franck

Volltext

Periorbital postinflammatory hyperpigmentation after plasma exeresis von Nipshagen, Martine D., Velthuis, Peter J., Mosmuller, David G. M.

Volltext